☆ 4.6 Article

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Related references

Note: Only part of the references are listed.

Editorial Material Hematology

Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination

Eun-Ju Lee et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Hematology

Redefining outcomes in immune TTP: an international working group consensus report

Adam Cuker et al.

Summary: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a potentially fatal disease caused by severe deficiency of ADAMTS13, and standardized definitions of response and exacerbation primarily based on platelet count have been modified to incorporate ADAMTS13 activity and the effects of anti-VWF therapy. The revised definitions distinguish between clinical and ADAMTS13 remission and relapse, and are benchmarked against not only the timing of discontinuation of therapeutic plasma exchange (TPE) but also that of anti-VWF therapy. Validation of the revised definitions is retrospective, with discussion on the clinical implications of the updated outcome definitions.

BLOOD (2021)

Add to Collection

Letter Immunology

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases

Rossella Talotta

CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Hematology

Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

Paul Knoebl et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Letter Hematology

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19

Nil Albiol et al.

ANNALS OF HEMATOLOGY (2020)

Add to Collection

Article Hematology

External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment

A. Li et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Add to Collection

Review Immunology

Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction

Yahel Segal et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Add to Collection

Review Hematology

Thrombotic thrombocytopenic purpura

Berangere S. Joly et al.

BLOOD (2017)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015

Evaren E. Page et al.

BLOOD ADVANCES (2017)

Add to Collection

Article Hematology

Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes

Marie Scully et al.

BLOOD (2014)

Add to Collection

Article Hematology

Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination

Yuki Kojima et al.

BLOOD COAGULATION & FIBRINOLYSIS (2014)

Add to Collection

Letter Hematology

Rabies vaccine-associated thrombotic thrombocytopenic purpura

G. Kadikoylu et al.

TRANSFUSION MEDICINE (2014)

Add to Collection

Letter Hematology

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

Marie Scully et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Add to Collection

Article Anesthesiology

Refractory thrombotic thrombocytopenic purpura following influenza vaccination

P. J. Dias et al.

ANAESTHESIA (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.